Table 1.
Medium | Drug (T, M, P concn)a | Statisticb | Total no. of bottles | No. of bottles with indicated Bactec result (% of bottles) |
No. of bottles with indicated TREK result (% of bottles) |
P value for: |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Control | Trough | Midlevel | Peak | Control | Trough | Midlevel | Peak | Control | Trough | Midlevel | Peak | ||||
Aerobic | Recovered | 84 | 84 (100) | 65 (77.4) | 50 (59.5) | 33 (39.3) | 84 (100) | 35 (41.7) | 10 (11.9) | 2 (2.4) | 1.000 | <0.001 | <0.001 | <0.001 | |
Avg TTD | 12.6 | 18 | 20.9 | 23 | 12.7 | 20.1 | 38.2 | 21.3 | |||||||
Combined | 148/252 (58.7) | 47/252 (18.6) | |||||||||||||
Anaerobic | Recovered | 30 | 30 (100) | 19 (63.3) | 16 (53.3) | 15 (50) | 29 (96.7) | 6 (20) | 5 (16.7) | 0 (0) | 1.000 | <0.001 | 0.006 | <0.001 | |
Avg TTD | 11.8 | 18 | 25 | 30 | 15.8 | 14.8 | 47.4 | NAc | |||||||
Combined | 50/90 (55.5) | 11/90 (12.2) | |||||||||||||
Overall | 114 | 114 (100) | 198/342 (57.8) | 113 (99.1) | 58/342 (16.9) | ||||||||||
Aerobic | Ampicillin (3, 12, 47) | Recovered | 9 | 9 (100) | 9 (100) | 6 (66.7) | 3 (33.3) | 9 (100) | 4 (44.4) | 0 (0) | 1 (11.1) | 1.000 | 0.029 | 0.009 | 0.577 |
Avg TTD | 11.3 | 16.2 | 20.9 | 21.8 | 11.8 | 25.1 | NA | 30.7 | |||||||
Anaerobic | Recovered | 6 | 6 (100) | 4 (66.7) | 1 (16.7) | 0 (0) | 5 (83.3) | 0 (0) | 0 (0) | 0 (0) | 1.000 | 0.061 | 1.000 | 1.000 | |
Avg TTD | 11.3 | 21.1 | 63.8 | NA | 16.4 | NA | NA | NA | |||||||
Aerobic | Cefepime (4, 19, 164) | Recovered | 12 | 12 (100) | 6 (50) | 3 (25) | 0 (0) | 12 (100) | 6 (50) | 0 (0) | 0 (0) | 1.000 | 1.000 | 0.217 | 1.000 |
Avg TTD | 13.6 | 20.8 | 32 | NA | 12.8 | 33.4 | NA | NA | |||||||
Aerobic | Ceftriaxone (15, 46, 250) | Recovered | 9 | 9 (100) | 0 (0) | 0 (0) | 0 (0) | 9 (100) | 0 (0) | 0 (0) | 0 (0) | ||||
Avg TTD | 12.1 | NA | NA | NA | 13.3 | NA | NA | NA | |||||||
Anaerobic | Recovered | 9 | 9 (100) | 0 (0) | 0 (0) | 0 (0) | 9 (100) | 0 (0) | 0 (0) | 0 (0) | |||||
Avg TTD | 12.5 | NA | NA | NA | 17.6 | NA | NA | NA | |||||||
Aerobic | Levofloxacin (1.3, 4.5, 12) | Recovered | 18 | 18 (100) | 14 (77.8) | 10 (55.6) | 7 (38.9) | 10 (100) | 13 (72.2) | 8 (44.4) | 0 (0) | 1.000 | 1.000 | 0.740 | 0.008 |
Avg TTD | 13.5 | 14.7 | 16 | 12.2 | 13.6 | 18.6 | 37.2 | NA | |||||||
Anaerobic | Recovered | 6 | 6 (100) | 6 (100) | 6 (100) | 6 (100) | 6 (100) | 6 (100) | 5 (83.3) | 0 (0) | 1.000 | 1.000 | 1.000 | 0.002 | |
Avg TTD | 11.6 | 11 | 11.3 | 11.6 | 13.1 | 14.8 | 47.4 | NA | |||||||
Aerobic | Piperacillin-tazobactam (1.4-0.2, 16-2, 298-37) | Recovered | 12 | 12 (100) | 12 (100) | 9 (75) | 4 (33.3) | 12 (100) | 12 (100) | 2 (16.7) | 0 (0) | 1.000 | 1.000 | 0.012 | 0.093 |
Avg TTD | 14.3 | 14.2 | 16.9 | 16.9 | 13.2 | 13.5 | 42.4 | ||||||||
Aerobic | Vancomycin (10, 25, 50) | Recovered | 24 | 24 (100) | 24 (100) | 22 (91.7) | 19 (79.2) | 24 (100) | 0 (0) | 0 (0) | 1 (4.2) | 1.000 | <0.001 | <0.001 | <0.001 |
Avg TTD | 11.2 | 21.7 | 23.3 | 28.4 | 11.9 | NA | NA | 11.9 | |||||||
Anaerobic | Recovered | 9 | 9 (100) | 9 (100) | 9 (100) | 9 (100) | 9 (100) | 0 (0) | 0 (0) | 0 (0) | |||||
Avg TTD | 11.7 | 21.3 | 29.8 | 42.2 | 15.4 | NA | NA | NA |
Antibiotic concentrations (μg/ml) at trough, midlevel, and peak.
“Recovered” means the number of bottles from which organisms were recovered. TTDs are in hours (values are rounded to the nearest decimal). “Combined” means the summed number of T, M, and P bottles in which organisms were recovered/total number of bottles tested.
NA, not applicable (no organism growth in any bottles).